OBJECTIVE: To describe cardiovascular disease (CVD) risk management in Indigenous primary health care. DESIGN, SETTING AND PARTICIPANTS: Review of 1165 randomly selected case records of Indigenous Australian adults, aged >/= 18 years, regularly attending eight health services in diverse settings in New South Wales, Queensland and Central Australia, October 2007 - May 2008. MAIN OUTCOME MEASURE: Adherence to CVD risk screening and management guidelines, especially with respect to overall or absolute CVD risk. RESULTS: More than half the people in the sample (53%) were not adequately screened for CVD risk according to national recommendations. Underscreening was significantly associated with younger age, less frequent attendance, and lower uptake of the Medicare Health Assessment. Of the sample, 9% had established CVD, and 29% of those aged >/= 30 years were classified as high risk according to the 2004 National Heart Foundation of Australia (NHFA) adjusted Framingham equation. Of those with CVD, 40% (95% CI, 30%-50%) were not prescribed a combination of blood pressure (BP) medicines, statins and antiplatelet agents, and 56% (95% CI, 49%-62%) of high-risk individuals without CVD were not prescribed BP medicines and statins. For high-risk individuals not prescribed BP medicines or statins, 74% (95% CI, 64%-84%) and 30% (95% CI, 23%-39%) respectively, did not meet 2004 NHFA criteria for prescribing of these medications, and of those already prescribed BP medicines or statins, 41% (95% CI, 36%-47%) and 59% (95% CI, 52%-66%) did not meet respective guideline targets. CONCLUSIONS: These management gaps are similar to those found in non-Indigenous health care settings, suggesting deficiencies across the health system. Prescribing guidelines which exclude many high-risk individuals contribute to suboptimal management. Guideline reform and improved health service capacity could substantially improve Indigenous vascular health.
OBJECTIVE: To describe cardiovascular disease (CVD) risk management in Indigenous primary health care. DESIGN, SETTING AND PARTICIPANTS: Review of 1165 randomly selected case records of Indigenous Australian adults, aged >/= 18 years, regularly attending eight health services in diverse settings in New South Wales, Queensland and Central Australia, October 2007 - May 2008. MAIN OUTCOME MEASURE: Adherence to CVD risk screening and management guidelines, especially with respect to overall or absolute CVD risk. RESULTS: More than half the people in the sample (53%) were not adequately screened for CVD risk according to national recommendations. Underscreening was significantly associated with younger age, less frequent attendance, and lower uptake of the Medicare Health Assessment. Of the sample, 9% had established CVD, and 29% of those aged >/= 30 years were classified as high risk according to the 2004 National Heart Foundation of Australia (NHFA) adjusted Framingham equation. Of those with CVD, 40% (95% CI, 30%-50%) were not prescribed a combination of blood pressure (BP) medicines, statins and antiplatelet agents, and 56% (95% CI, 49%-62%) of high-risk individuals without CVD were not prescribed BP medicines and statins. For high-risk individuals not prescribed BP medicines or statins, 74% (95% CI, 64%-84%) and 30% (95% CI, 23%-39%) respectively, did not meet 2004 NHFA criteria for prescribing of these medications, and of those already prescribed BP medicines or statins, 41% (95% CI, 36%-47%) and 59% (95% CI, 52%-66%) did not meet respective guideline targets. CONCLUSIONS: These management gaps are similar to those found in non-Indigenous health care settings, suggesting deficiencies across the health system. Prescribing guidelines which exclude many high-risk individuals contribute to suboptimal management. Guideline reform and improved health service capacity could substantially improve Indigenous vascular health.
Authors: Hueiming Liu; Anushka Patel; Alex Brown; Sandra Eades; Noel Hayman; Stephen Jan; Ian Ring; Greg Stewart; Andrew Tonkin; Tarun Weeramanthri; Vicki Wade; Anthony Rodgers; Tim Usherwood; Bruce Neal; David Peiris; Hugh Burke; Christopher Reid; Alan Cass Journal: BMC Public Health Date: 2010-08-05 Impact factor: 3.295
Authors: Sze Lin Yoong; Mariko Leanne Carey; Robert William Sanson-Fisher; Grant Russell; Danielle Mazza; Meredith Makeham; Christine Louise Paul; Kerry Jane Inder; Catherine D'Este Journal: BMJ Open Date: 2012-07-02 Impact factor: 2.692
Authors: David Peiris; Tim Usherwood; Katie Panaretto; Mark Harris; Jenny Hunt; Bindu Patel; Nicholas Zwar; Julie Redfern; Stephen Macmahon; Stephen Colagiuri; Noel Hayman; Anushka Patel Journal: BMJ Open Date: 2012-11-19 Impact factor: 2.692
Authors: Christopher P Burgess; Ross S Bailie; Christine M Connors; Richard D Chenhall; Robyn A McDermott; Kerin O'Dea; Charlie Gunabarra; Hellen L Matthews; Adrian J Esterman Journal: BMC Health Serv Res Date: 2011-01-31 Impact factor: 2.655
Authors: Julie Redfern; T Usherwood; M F Harris; A Rodgers; N Hayman; K Panaretto; C Chow; A Y S Lau; L Neubeck; G Coorey; F Hersch; E Heeley; A Patel; S Jan; N Zwar; D Peiris Journal: BMJ Open Date: 2014-01-31 Impact factor: 2.692
Authors: David P Peiris; Rohina Joshi; Ruth J Webster; Patrick Groenestein; Tim P Usherwood; Emma Heeley; Fiona M Turnbull; Alexandra Lipman; Anushka A Patel Journal: J Med Internet Res Date: 2009-12-17 Impact factor: 5.428
Authors: K S Panaretto; K L Gardner; S Button; A Carson; R Schibasaki; G Wason; D Baker; J Mein; A Dellit; D Lewis; M Wenitong; I Ring Journal: BMJ Open Date: 2013-04-11 Impact factor: 2.692
Authors: David Peiris; Alex Brown; Michael Howard; Bernadette A Rickards; Andrew Tonkin; Ian Ring; Noel Hayman; Alan Cass Journal: BMC Health Serv Res Date: 2012-10-28 Impact factor: 2.655
Authors: Natasha E Noble; Christine L Paul; Mariko L Carey; Robert W Sanson-Fisher; Stephen V Blunden; Jessica M Stewart; Katherine M Conigrave Journal: BMC Med Inform Decis Mak Date: 2014-04-16 Impact factor: 2.796